SE341239B - - Google Patents

Info

Publication number
SE341239B
SE341239B SE12297/67A SE1229767A SE341239B SE 341239 B SE341239 B SE 341239B SE 12297/67 A SE12297/67 A SE 12297/67A SE 1229767 A SE1229767 A SE 1229767A SE 341239 B SE341239 B SE 341239B
Authority
SE
Sweden
Application number
SE12297/67A
Inventor
H Bennich
S Johansson
L Wide
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE12297/67A priority Critical patent/SE341239B/xx
Priority to FR1588874D priority patent/FR1588874A/fr
Priority to DK418468AA priority patent/DK131400B/da
Priority to CH1313868A priority patent/CH534878A/de
Priority to CH115171A priority patent/CH551010A/xx
Priority to CH115071A priority patent/CH551009A/de
Priority to DE19681798417 priority patent/DE1798417A1/de
Priority to GB41801/68A priority patent/GB1248764A/en
Priority to GB3457/71A priority patent/GB1248765A/en
Priority to DE19681798418 priority patent/DE1798418A1/de
Priority to BE720341D priority patent/BE720341A/xx
Priority to DE19681798170 priority patent/DE1798170C2/de
Priority to NL6812559.A priority patent/NL162209C/xx
Priority to NO03458/68A priority patent/NO127685B/no
Priority to FI682498A priority patent/FI48785C/fi
Priority to AT873168A priority patent/AT288593B/de
Priority to CS686265A priority patent/CS191857B2/cs
Priority to AT359370A priority patent/AT295744B/de
Priority to JP43064219A priority patent/JPS50892B1/ja
Priority to ES357863A priority patent/ES357863A1/es
Priority to DK364870A priority patent/DK133205C/da
Priority to DK364770A priority patent/DK132970C/da
Publication of SE341239B publication Critical patent/SE341239B/xx
Priority to CA130948A priority patent/CA937142A/en
Priority to NO2477/72A priority patent/NO138182C/no
Priority to FI300973A priority patent/FI55409C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0058—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1015—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1078—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an immunoglobulin, i.e. being an (anti)-anti-idiotypic antibody
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE12297/67A 1967-09-06 1967-09-06 SE341239B (https=)

Priority Applications (25)

Application Number Priority Date Filing Date Title
SE12297/67A SE341239B (https=) 1967-09-06 1967-09-06
FR1588874D FR1588874A (https=) 1967-09-06 1968-08-28
DK418468AA DK131400B (da) 1967-09-06 1968-08-30 Fremgangsmåde til påvisning af eller bestemmelse in vitro af reagin-immunglobuliner (reagin-Ig) i en vandholdig prøve og rettet mod et givet allergen, og hjælpemiddel til anvendelse ved udøvelse af fremgangsmåden.
CH1313868A CH534878A (de) 1967-09-06 1968-09-02 Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wässrigen Proben
CH115171A CH551010A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung eines markierten reagin-immunoglobulins.
CH115071A CH551009A (de) 1967-09-06 1968-09-02 Verfahren zur herstellung markierter antikoerper gegen reagin-immunoglobuline.
DE19681798170 DE1798170C2 (de) 1967-09-06 1968-09-03 Verfahren zur Bestimmung der Anwesenheit von gegen bestimmte Allergene gerichteten Reagin-Immunoglobulinen (Reagin-Ig) in wäßrigen Proben
GB41801/68A GB1248764A (en) 1967-09-06 1968-09-03 Antibodies against reagin-immunoglobulins (reagin-ig), and their use
GB3457/71A GB1248765A (en) 1967-09-06 1968-09-03 Reagin-immunoglobulins (reagin-ig) and their use
DE19681798418 DE1798418A1 (de) 1967-09-06 1968-09-03 Markierte Antikoerper gegen Reagin-Immunoglobuline
BE720341D BE720341A (https=) 1967-09-06 1968-09-03
DE19681798417 DE1798417A1 (de) 1967-09-06 1968-09-03 Markierte Reagin-Immunoglobuline (Reagin-Ig)
NL6812559.A NL162209C (nl) 1967-09-06 1968-09-04 Werkwijze voor het aantonen van tegen allergenen gerichte reagin-immunoglobulinen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
NO03458/68A NO127685B (https=) 1967-09-06 1968-09-05
FI682498A FI48785C (fi) 1967-09-06 1968-09-05 Menetelmä ja apuaine tiettyyn allergeeniin vaikuttavien reagiini-immun oglobuliinien (reagin-Ig) toteamiseksi vesipitoisissa näytteissä.
AT873168A AT288593B (de) 1967-09-06 1968-09-06 Verfahren zur Bestimmung von gegen bestimmte Allergene wirkenden Reagin-Immunoglobulinen (Reagin-Ig) in wässerigen Testproben
CS686265A CS191857B2 (en) 1967-09-06 1968-09-06 Means for detecting the reagin-immunoglobulines
AT359370A AT295744B (de) 1967-09-06 1968-09-06 Verfahren zur Herstellung markierter Antikörper gegen Reagin-Immunoglobuline
JP43064219A JPS50892B1 (https=) 1967-09-06 1968-09-06
ES357863A ES357863A1 (es) 1967-09-06 1969-09-05 Un metodo para determinar la presencia de reagin-inmunoglo-bulinas.
DK364870A DK133205C (da) 1967-09-06 1970-07-14 Middel bestaende af eller indeholdende mindst et immunglobulin tilhorende reagin-immunglobulin-klassen og beregnet til anvendelse ved immunkemiske reaktioner in vitro i vandholdig veske
DK364770A DK132970C (da) 1967-09-06 1970-07-14 Immunkemisk reagens bestaende af eller indeholdende antistoffer der er specifikt rettet mod reagin-ig eller fragmenter deraf
CA130948A CA937142A (en) 1967-09-06 1971-12-23 Reagin-immunoglobulins (reagin-ig) and their use
NO2477/72A NO138182C (no) 1967-09-06 1972-07-11 Antilegemer spesifikt rettet mot immunglobulin e (ige) eller mot fragment av ige.
FI300973A FI55409C (fi) 1967-09-06 1973-09-26 Maerkta antikroppar mot immunglobulin e

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE12297/67A SE341239B (https=) 1967-09-06 1967-09-06

Publications (1)

Publication Number Publication Date
SE341239B true SE341239B (https=) 1971-12-20

Family

ID=20295495

Family Applications (1)

Application Number Title Priority Date Filing Date
SE12297/67A SE341239B (https=) 1967-09-06 1967-09-06

Country Status (13)

Country Link
JP (1) JPS50892B1 (https=)
AT (2) AT295744B (https=)
BE (1) BE720341A (https=)
CH (1) CH534878A (https=)
CS (1) CS191857B2 (https=)
DK (1) DK131400B (https=)
ES (1) ES357863A1 (https=)
FI (1) FI48785C (https=)
FR (1) FR1588874A (https=)
GB (1) GB1248764A (https=)
NL (1) NL162209C (https=)
NO (2) NO127685B (https=)
SE (1) SE341239B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US4054646A (en) 1973-07-30 1977-10-18 General Electric Method and apparatus for detection of antibodies and antigens
US3966897A (en) * 1973-04-02 1976-06-29 Marine Colloids, Inc. Medium for use in bioassay and method of using same
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
GB1555142A (en) * 1975-08-14 1979-11-07 Sinai School Medicine Blood cell typing and compatibility test procedure
AT343822B (de) * 1976-08-20 1978-06-26 Immuno Ag Radioimmunologisches verfahren und einrichtung zur bestimmung von antigenen
US4289748A (en) * 1979-05-31 1981-09-15 United States Of America Ultrasensitive enzymatic radioimmunoassay method
FR2502786B1 (fr) * 1981-03-24 1985-06-21 Stallergenes Laboratoire Procede de fixation d'antigenes et d'anticorps sur support de polysaccharides, et utilisation du produit ainsi obtenu pour les dosages immunologiques
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
NL8102178A (nl) * 1981-05-02 1982-12-01 Stichting Centraal Lab Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
JPS6199195U (https=) * 1984-11-30 1986-06-25

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE31006E (en) * 1968-09-24 1982-08-03 Akzona Incorporated Process for the demonstration and determination of reaction components having specific binding affinity for each other

Also Published As

Publication number Publication date
AT288593B (de) 1971-03-10
GB1248764A (en) 1971-10-06
FR1588874A (https=) 1970-03-16
ES357863A1 (es) 1970-04-01
CS191857B2 (en) 1979-07-31
NO127685B (https=) 1973-07-30
NO138182C (no) 1978-07-26
BE720341A (https=) 1969-02-17
DE1798170B1 (de) 1972-04-27
CH534878A (de) 1973-03-15
DK131400B (da) 1975-07-07
JPS50892B1 (https=) 1975-01-13
NL162209B (nl) 1979-11-15
NL6812559A (https=) 1969-03-10
DK131400C (https=) 1975-11-24
NO138182B (no) 1978-04-10
NL162209C (nl) 1980-04-15
AT295744B (de) 1972-01-10
FI48785C (fi) 1974-12-10
FI48785B (https=) 1974-09-02

Similar Documents

Publication Publication Date Title
AT298283B (https=)
DK131400C (https=)
AU2256867A (https=)
AU3189468A (https=)
AU2116667A (https=)
AU2528767A (https=)
AU2454867A (https=)
AU1273466A (https=)
BE710371A (https=)
BE693070A (https=)
AU1614766A (https=)
BE711937A (https=)
BE711525A (https=)
BE711464A (https=)
AU23366A (https=)
BE711397A (https=)
BE711189A (https=)
BE711120A (https=)
BE710559A (https=)
BE693071A (https=)
BE710285A (https=)
BE710139A (https=)
BE710136A (https=)
BE709619A (https=)
BE709427A (https=)